| POLAR CAPITAL BIOTECHNOLOGY S EUR DIS | BIOTECNOLOGÍA | 53,59% | 67,31% | 76,80% | 353,36% |
| SCHRODER ISF JAPANESE OPPORTUNITIES I ACC USD (HEDGED) | RVI JAPÓN VALOR | 52,85% | 116,54% | 185,88% | 353,12% |
| LORD ABBETT INNOVATION GROWTH FUND Z USD CAP | RVI GLOBAL CRECIMIENTO | 25,44% | 93,03% | 49,37% | 351,84% |
| BNP PARIBAS JAPAN SMALL CAP PRIVILEGE H EUR CAP | RVI JAPÓN SMALL/MID CAP | 67,42% | 143,97% | 154,34% | 351,54% |
| ALGER SICAV - ALGER AMERICAN ASSET GROWTH FUND I EUH | RVI USA CRECIMIENTO | 48,19% | 140,39% | 78,02% | 351,51% |
| POLAR CAPITAL BIOTECHNOLOGY S GBP DIS | BIOTECNOLOGÍA | 53,53% | 67,38% | 76,91% | 351,20% |
| CHALLENGE TECHNOLOGY EQUITY EVOLUTION L-A | TMT | 38,71% | 101,26% | 64,59% | 350,91% |
| FIDELITY FUNDS-JAPAN VALUE A-DIST-EUR (HEDGED) | RVI JAPÓN VALOR | 58,09% | 125,45% | 165,65% | 350,73% |
| GOLDMAN SACHS JAPAN EQUITY PARTNERS PORTFOLIO I H USD CAP | RVI JAPÓN | 28,24% | 81,86% | 117,78% | 349,59% |
| POLAR CAPITAL BIOTECHNOLOGY S USD DIS | BIOTECNOLOGÍA | 53,39% | 66,06% | 76,94% | 349,28% |
